128 related articles for article (PubMed ID: 38431223)
21. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
22. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
Burke KE; Nayor J; Campbell EJ; Ananthakrishnan AN; Khalili H; Richter JM
Dig Dis Sci; 2020 Jan; 65(1):111-118. PubMed ID: 31367882
[TBL] [Abstract][Full Text] [Related]
23. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
24. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Collins PD; Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
[TBL] [Abstract][Full Text] [Related]
25. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
Ullman T; Croog V; Harpaz N; Sachar D; Itzkowitz S
Gastroenterology; 2003 Nov; 125(5):1311-9. PubMed ID: 14598247
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study.
Derks ME; Te Groen M; Peters CP; Dijkstra G; de Vries AC; Romkens TE; Horjus CS; de Boer NK; Bemelman WA; Nagtegaal ID; Derikx LA; Hoentjen F;
Int J Surg; 2023 Jul; 109(7):1961-1969. PubMed ID: 37300890
[TBL] [Abstract][Full Text] [Related]
27. Prediction of the Risk of a Metachronous Advanced Colorectal Neoplasm Using a Novel Scoring System.
Lee JY; Park HW; Kim MJ; Lee JS; Lee HS; Chang HS; Choe J; Hwang SW; Yang DH; Myung SJ; Yang SK; Byeon JS
Dig Dis Sci; 2016 Oct; 61(10):3016-3025. PubMed ID: 27358228
[TBL] [Abstract][Full Text] [Related]
28. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
29. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
30. Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD.
Shah SC; Itzkowitz SH
J Crohns Colitis; 2020 Sep; 14(8):1172-1177. PubMed ID: 32150256
[TBL] [Abstract][Full Text] [Related]
31. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
32. Optimization of the surveillance strategy in patients with colorectal adenomas: A combination of clinical parameters and index colonoscopy findings.
Park CH; Jung YS; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2021 Apr; 36(4):974-982. PubMed ID: 32869895
[TBL] [Abstract][Full Text] [Related]
33. Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship.
Wijnands AM; Elias SG; Dekker E; Fidder HH; Hoentjen F; Ten Hove JR; Maljaars PWJ; van der Meulen-de Jong AE; Mooiweer E; Ouwehand RJ; Penning de Vries BBL; Ponsioen CY; van Schaik FDM; Oldenburg B;
United European Gastroenterol J; 2023 Sep; 11(7):612-620. PubMed ID: 37505117
[TBL] [Abstract][Full Text] [Related]
34. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Zhang R; Lauwers GY; Choi WT
J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
[TBL] [Abstract][Full Text] [Related]
35. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
37. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
[TBL] [Abstract][Full Text] [Related]
38. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
40. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
